Validating Electronic Monitoring of Medication in Kidney Transplant Patients
Author Information
Author(s): Denhaerynck Kris, Schäfer-Keller Petra, Young James, Steiger Jürg, Bock Andreas, De Geest Sabina
Primary Institution: Institute of Nursing Science, University of Basel
Hypothesis
What assumptions are necessary for the internal and external validity of electronic monitoring (EM) measurement of medication adherence?
Conclusion
The study found that several assumptions for the validity of electronic monitoring were not fulfilled, indicating potential biases in measuring medication adherence.
Supporting Evidence
- 62% of patients reported discrepancies between recorded openings and actual medication intakes.
- One EM cap malfunctioned, affecting data accuracy.
- Adherence decreased over the first 5 weeks of monitoring, indicating a waning intervention effect.
Takeaway
This study looked at how well electronic monitoring works for tracking if kidney transplant patients take their medicine. It found that sometimes the monitoring doesn't match up with what patients actually do.
Methodology
Data from the SMART study was used, involving 250 adult renal transplant patients monitored for 3 months using the Medication Event Monitoring System (MEMS).
Potential Biases
Potential biases include self-reporting discrepancies and the influence of being monitored on patients' adherence behavior.
Limitations
The study's findings may not be generalizable to all populations using EM, and the sample was limited to kidney transplant patients in Switzerland.
Participant Demographics
The average age of participants was 54 years, with 57% male and 84% Swiss citizens.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 1.17–1.46
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website